Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Idris Guessous and Nicolas Vuilleumier.
Idris Guessous
Connection Strength
1.959
Nicolas Vuilleumier
  1. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest. 2021 Nov; 51(11):e13661.
    View in: PubMed
    Score: 0.240
  2. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455.
    View in: PubMed
    Score: 0.237
  3. Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med. 2021 Apr 10; 10(8).
    View in: PubMed
    Score: 0.235
  4. Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters. Front Public Health. 2020; 8:626090.
    View in: PubMed
    Score: 0.232
  5. Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020 Jul 24; 9(8).
    View in: PubMed
    Score: 0.223
  6. Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution. Lancet Digit Health. 2020 08; 2(8):e393-e394.
    View in: PubMed
    Score: 0.222
  7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
    View in: PubMed
    Score: 0.222
  8. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
    View in: PubMed
    Score: 0.060
  9. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643.
    View in: PubMed
    Score: 0.059
  10. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021 May 27.
    View in: PubMed
    Score: 0.059
  11. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021 05; 21(5):600-601.
    View in: PubMed
    Score: 0.058
  12. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
    View in: PubMed
    Score: 0.056
  13. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct; 26(10):1386-1394.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.